Rhythm Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $71,255 | $60,112 | $57,253 | $51,298 |
Gross Profit | 62,324 | 52,955 | 52,451 | 45,799 |
EBITDA | -44,063 | -50,259 | -42,649 | -47,747 |
EBIT | -44,314 | -50,511 | -42,921 | -48,051 |
Net Income | -49,298 | -55,639 | -47,505 | -52,904 |
Net Change In Cash | 71,255 | 60,112 | 57,253 | 51,298 |
Free Cash Flow | -53,337 | -44,185 | -26,342 | -26,622 |
Cash | 65,614 | 62,137 | 54,301 | 52,078 |
Basic Shares | 68,592 | 67,974 | 66,876 | 64,346 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $189,757 | $130,126 | $77,428 | $23,638 |
Gross Profit | 170,265 | 116,758 | 68,126 | 21,505 |
EBITDA | -174,121 | -238,090 | -168,464 | -174,246 |
EBIT | -175,459 | -239,653 | -170,222 | -175,918 |
Net Income | -196,539 | -260,602 | -184,678 | -181,119 |
Net Change In Cash | 189,757 | 130,126 | 77,428 | 23,638 |
Cost of Revenue | 68,429 | |||
Free Cash Flow | -116,628 | -113,879 | -136,204 | -177,709 |
Cash | 54,301 | 89,137 | 60,081 | 127,677 |
Basic Shares | 64,984 | 60,995 | 57,673 | 52,120 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.73 |
2026-03-31 | -$0.83 |
2025-12-31 | -$0.73 |
2025-09-30 | -$0.82 |